Mortality in alzheimer's disease
Pro Research Analysisby 
Searched over 200M research papers
Alzheimer’s Disease Mortality Trends and Public Health Impact
Alzheimer’s disease (AD) is a leading cause of death worldwide, with mortality rates rising significantly over recent decades. In the United States, the number of deaths attributed to AD increased from 44,536 in 1999 to 122,019 in 2018, with the age-adjusted mortality rate nearly doubling from 16.5 to 30.5 per 100,000 during this period. Projections indicate that this rate could reach 42.4 per 100,000 by 2023, highlighting a growing public health burden as the population ages Zhao20215Gaugler2016+2 MORE. Similar trends are observed in China, where the crude mortality rate for AD and other dementias rose from 3.7 to 6.2 per 100,000 between 2011 and 2020, and is expected to continue increasing, reflecting the impact of an aging population .
Mortality Risk Factors in Alzheimer’s Disease
Several factors influence mortality in individuals with AD. Age and the severity of cognitive decline are the most significant predictors of mortality, with older age and more advanced disease associated with shorter survival Bonsignore2003Bowen1996. Additional factors such as general debility, sensory impairment (especially affecting the ability to read), and comorbid vascular disease also contribute to increased mortality risk . Gender differences have been noted, with some studies indicating that AD increases mortality risk more in women than in men . However, other variables such as the duration of illness, rate of cognitive decline, and genetic factors like the apolipoprotein E4 allele do not appear to significantly affect mortality .
Survival Duration and Causes of Death
The average duration of survival after an AD diagnosis is approximately 5.9 years, with earlier age at onset associated with longer survival . Five-year mortality rates for people with AD are estimated at around 35%, which is about double that of the age-matched general population . Common causes of death among individuals with AD include complications such as pneumonia and dehydration, while cancer is less frequently listed as a cause of death in this population .
Comorbidities and Excess Mortality
People with AD are more likely to have comorbid conditions such as cardiovascular disease and diabetes compared to those without dementia, further increasing their risk of mortality . The population-attributable risk of mortality from AD in elderly cohorts is estimated at nearly 5% . The burden of years of life lost due to AD has also increased substantially, underscoring the disease’s impact on longevity and quality of life .
Societal and Economic Burden
AD is consistently ranked as the sixth leading cause of death in the United States and the fifth among Americans aged 65 and older 5Gaugler2016Anonymous2021+1 MORE. The number of deaths attributed to AD has increased by more than 145% between 2000 and 2019, even as deaths from other major diseases have declined Anonymous2021Anonymous2022. The societal burden extends beyond mortality, with significant impacts on caregivers and healthcare systems. The costs of care for individuals with AD are several times higher than for those without dementia, and unpaid caregiving by family members represents a substantial economic and emotional burden 5Gaugler2016Anonymous2021+1 MORE.
Conclusion
Mortality in Alzheimer’s disease is rising globally, driven by aging populations and the lack of effective disease-modifying treatments. Age, disease severity, and comorbidities are key factors influencing survival. The growing burden of AD mortality highlights the urgent need for improved prevention, early diagnosis, and comprehensive care strategies to address both the direct and indirect impacts of the disease Zhao2021Lanctôt20235+5 MORE.
Sources and full results
Most relevant research papers on this topic